Literature DB >> 23313806

Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update.

Mandeep Kumar Arora1, Umesh Kumar Singh.   

Abstract

Diabetes mellitus is known to trigger retinopathy, neuropathy and nephropathy. Diabetic nephropathy, a long-term major microvascular complication of uncontrolled hyperglycemia, affects a large population worldwide. Recent findings suggest that numerous pathways are activated during the course of diabetes mellitus and that these pathways individually or collectively play a role in the induction and progression of diabetic nephropathy. However, clinical strategies targeting these pathways to manage diabetic nephropathy remain unsatisfactory, as the number of diabetic patients with nephropathy is increasing yearly. To develop ground-breaking therapeutic options to prevent the development and progression of diabetic nephropathy, a comprehensive understanding of the molecular mechanisms involved in the pathogenesis of the disease is mandatory. Therefore, the purpose of this paper is to discuss the underlying mechanisms and downstream pathways involved in the pathogenesis of diabetic nephropathy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23313806     DOI: 10.1016/j.vph.2013.01.001

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  61 in total

1.  Effect of strawberry (Fragaria × ananassa) leaf extract on diabetic nephropathy in rats.

Authors:  Doaa S Ibrahim; Marwa A E Abd El-Maksoud
Journal:  Int J Exp Pathol       Date:  2015-02-03       Impact factor: 1.925

2.  Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy.

Authors:  Min Wang; Di Yao; Suyu Wang; Qin Yan; Weiping Lu
Journal:  Endocrine       Date:  2016-04-15       Impact factor: 3.633

3.  Renal cortical stiffness obtained by shear wave elastography imaging is increased in patients with type 2 diabetes mellitus without diabetic nephropathy.

Authors:  Ayse Selcan Koc; Hılmı Erdem Sumbul
Journal:  J Ultrasound       Date:  2018-07-26

4.  Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy.

Authors:  Vemana Gowd; Qingzheng Kang; Qi Wang; Qiang Wang; Feng Chen; Ka-Wing Cheng
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

5.  Peripheral blood mitochondrial DNA copy number as a novel potential biomarker for diabetic nephropathy in type 2 diabetes patients.

Authors:  Ghada Al-Kafaji; Abdulah Aljadaan; Amer Kamal; Moiz Bakhiet
Journal:  Exp Ther Med       Date:  2018-06-15       Impact factor: 2.447

6.  PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.

Authors:  Esraa M Zakaria; Nabila N El-Maraghy; Ahmed F Ahmed; Abdelmonim A Ali; Hany M El-Bassossy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-21       Impact factor: 3.000

Review 7.  The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.

Authors:  Maryam Teimouri; Hossein Hosseini; Zahra ArabSadeghabadi; Reyhaneh Babaei-Khorzoughi; Sattar Gorgani-Firuzjaee; Reza Meshkani
Journal:  J Physiol Biochem       Date:  2022-01-06       Impact factor: 4.158

8.  Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!

Authors:  Vajir Malek; Sachin V Suryavanshi; Nisha Sharma; Yogesh A Kulkarni; Shrikant R Mulay; Anil Bhanudas Gaikwad
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

Review 9.  Ion channels and transporters in diabetic kidney disease.

Authors:  Denisha Spires; Anna D Manis; Alexander Staruschenko
Journal:  Curr Top Membr       Date:  2019-02-18       Impact factor: 3.049

Review 10.  The Role of Finerenone in the Management of Diabetic Nephropathy.

Authors:  Stavroula Veneti; Konstantinos Tziomalos
Journal:  Diabetes Ther       Date:  2021-05-29       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.